ArticleMediterranean journal of rheumatology2025
Age, Gender, and Disease Duration as Key Determinants of Comorbidity Burden in Spondyloarthritis: A Multicentre Cross-Sectional Study.
Article in Mediterranean journal of rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The burden of comorbidities associated with spondylarthritis (SpA) in India remains relatively unexplored, with most existing research limited to specific regions. This study aimed to evaluate the prevalence and patterns of comorbidities among SpA patients across India. Methods: This multicentre, observational study was conducted at seven centres across India using data from the Indian Rheumatology Association database. Comorbidities were classified according to the ICD-10 Charlson Comorbidity Index. Patients were stratified into two age groups (>50 vs. ≤50 years). Statistical analyses included descriptive statistics, Fisher's exact test, chi-square test, two-tailed t-test, and logistic regression to identify predictors of comorbidity. Results: Of 1,250 SpA patients (mean age 39.8 ± 13.3 years), 25% had comorbidities. The most common were hypertension (11.8%) and diabetes (8.5%), including 1.1% with complications. Comorbidities were significantly more frequent in patients >50 years (55.3%) vs ≤50 years (16.6%, P < 0.001). Older age was associated with higher rates of diabetes (24.5% vs. 4.0%), hypertension (32.6% vs. 6.0%), and thyroid disorders (9.5% vs. 2.8%) (P < 0.001 for all). Logistic regression revealed age as the strongest predictor for hypertension (P < 0.001, Wald = 101.3), diabetes (P < 0.001), hyperlipidaemia (P = 0.022), and thyroid disorders (P = 0.003). Female gender was associated with thyroid disorders (P < 0.001), and longer disease duration with diabetes (P = 0.022). Conclusion: This study underscores a substantial comorbidity burden among Indian SpA patients, highlighting the need for comprehensive screening and management strategies, particularly in older patients and those with longer disease duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.